TNF receptor I on human keratinocytes is a binding partner for staphylococcal protein A resulting in the activation of NF kappa B, AP 1, and downstream gene transcription

Experimental Dermatology

Volumn 20, Issue 1, 2011, Pages 48-52

  Claßen, Anna ^a   Kalali, Behnam N ^a   Schnopp, Christina ^a   Andres, Christian ^a   Aguilar Pimentel, Juan A ^a   Ring, Johannes ^a   Ollert, Markus ^a   Mempel, Martin ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Keratinocytes; Protein A; Staphylococcus aureus; TNF RI

Indexed keywords

AP 1 PROTEIN; CELL EXTRACT; CYCLOOXYGENASE 2; HEMOLYSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MEMBRANE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; STAPHYLOCOCCUS PROTEIN A; STRESS ACTIVATED PROTEIN KINASE 1; SUPERANTIGEN; SYNAPTOPHYSIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; BACTERIAL CELL WALL; CELL NUCLEUS; CONTROLLED STUDY; EPIDERMIS; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; KERATINOCYTE; NEWBORN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

ACTIVE TRANSPORT, CELL NUCLEUS; BASE SEQUENCE; CELL LINE; CELLS, CULTURED; CYCLOOXYGENASE 2; DERMATITIS, ATOPIC; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; KERATINOCYTES; PROTEIN BINDING; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; STAPHYLOCOCCAL PROTEIN A; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 78650217755     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01174.x     Document Type: Article

References (40)

1. Leyden J J, Marples R R, Kligman A M. Br J Dermatol 1974: 90: 525-530.
2. Aly R, Maibach H I, Shinefield H R. Arch Dermatol 1977: 113: 780-782.
3. Mempel M, Lina G, Hojka M et al. Eur J Clin Microbiol Infect Dis 2003: 22: 306-309.
4. Breuer K, S H A, Kapp A et al. Br J Dermatol 2002: 147: 55-61.
5. Hoeger P H, Lenz W, Boutonnier A et al. J Infect Dis 1992: 165: 1064-1068.
6. Cho S H, Strickland I, Boguniewicz M et al. J Allergy Clin Immunol 2001: 108: 269-274.
7. Kisich K O, Carspecken C W, Fieve S et al. J Allergy Clin Immunol 2008: 122: 62-68.
8. Mrabet-Dahbi S, Dalpke A H, Niebuhr M et al. J Allergy Clin Immunol 2008: 121: 1013-1019.
9. Niebuhr M, Langnickel J, Sigel S et al. Exp Dermatol 2010: 19: e296-e298.
10. Bunikowski R, Mielke M E, Skarabis H et al. J Allergy Clin Immunol 2000: 105: 814-819.
11. Bieber T. N Engl J Med 2008: 358: 1483-1494.
12. Miyata A, Natsuaki M, Yamanishi K. Exp Dermatol 2008: 17: 843-848.
13. Orfali R L, Sato M N, Takaoka R et al. Exp Dermatol 2009: 18: 628-633.
14. White M I, Noble W C. Br J Dermatol 1985: 113: 179-183.
15. Ezepchuk Y V, Leung D Y, Middleton M H et al. J Invest Dermatol 1996: 107: 603-609.
16. Aufiero B, Duanmu Z, Guo M et al. J Dermatol Sci 2004: 36: 173-175.
17. Kumar A, Tassopoulos A M, Li Q et al. Biochem Biophys Res Commun 2007: 354: 955-961.
18. Gomez M I, Lee A, Reddy B et al. Nat Med 2004: 10: 842-848.
19. Kalali B N, Kollisch G, Mages J et al. J Immunol 2008: 181: 2694-2704.
20. Mempel M, Voelcker V, Kollisch G et al. J Invest Dermatol 2003: 121: 1389-1396.
21. Kollisch G, Kalali B N, Voelcker V et al. Immunology 2005: 114: 531-541.
22. Van Belkum A, Riewarts Eriksen N H, Sijmons M et al. J Med Microbiol 1997: 46: 222-232.
23. Roben P W, Salem A N, Silverman G J. J Immunol 1995: 154: 6437-6445.
24. Gomez M I, O'Seaghdha M, Magargee M et al. J Biol Chem 2006: 281: 20190-20196.
25. Noble W C. Br J Dermatol 1998: 139 (Suppl. 53): 9-12.
26. DeDent A C, McAdow M, Schneewind O. J Bacteriol 2007: 189: 4473-4484.
27. Gauger A, Mempel M, Schekatz A et al. Dermatology 2003: 207: 15-21.
28. Hartleib J, Kohler N, Dickinson R B et al. Blood 2000: 96: 2149-2156.
29. Leong K G, Karsan A. Histol Histopathol 2000: 15: 1303-1325.
30. Hamid Q, Boguniewicz M, Leung D Y. J Clin Invest 1994: 94: 870-876.
31. Liu Y J. J Exp Med 2006: 203: 269-273.
32. Leung D Y, Travers J B, Norris D A. J Invest Dermatol 1995: 105: 37S-42S.
33. Mempel M, Schmidt T, Weidinger S et al. J Invest Dermatol 1998: 111: 452-456.
34. Boguniewicz M, Sampson H, Leung S B et al. J Allergy Clin Immunol 2001: 108: 651-652.
35. Lebre M C, van der Aar A M, van Baarsen L et al. J Invest Dermatol 2007: 127: 331-341.
36. Begon E, Michel L, Flageul B et al. Eur J Dermatol 2007: 17: 497-506.
37. Travers J B, Leung D Y, Johnson C et al. J Invest Dermatol 2003: 120: 789-794.
38. Wichmann K, Uter W, Weiss J et al. Br J Dermatol 2009: 161: 300-305.
39. Travers J B, Norris D A, Leung D Y. J Investig Dermatol Symp Proc 2001: 6: 225-230.
40. Travers J B, Kozman A, Mousdicas N et al. J Allergy Clin Immunol 2010: 125: 146-152.